From proprotein convertase subtilisin/kexin type 9 to its inhibition: state-of-the-art and clinical implications


Por: Navarese, EP, Kolodziejczak, M, Dimitroulis, D, Wolff, G, Busch, HL, Devito, F, Sionis, A, Ciccone, MM

Publicada: 1 ene 2016
Resumen:
Statins are recommended as first-line therapy for patients with hypercholesterolaemia. A sizable proportion of patients, however, does not reach therapeutic goals, is statin intolerant, or, despite optimal statin therapy, is at high risk of ischaemic events. Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a major role in lipid metabolism and several comorbidities. Monoclonal antibodies targeting PCSK9 are a new lipid-lowering approach with the potential to improve clinical outcomes in patients with dyslipidaemia. In this review, we discuss current experimental and clinical evidence of the role of PCSK9 and its inhibition on lipid metabolism and several pathologic conditions with a focus on clinical outcomes. A state-of-the-art analysis of current clinical evidence and future directions on PCSK9 and its inhibition is provided.

Filiaciones:
Navarese, EP:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dept Internal Med, Moorenstr 5, D-40225 Dusseldorf, Germany

Kolodziejczak, M:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Nicolaus Copernicus, Coll Med Bydgoszcz, Torun, Poland

Dimitroulis, D:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dept Internal Med, Moorenstr 5, D-40225 Dusseldorf, Germany

Wolff, G:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dept Internal Med, Moorenstr 5, D-40225 Dusseldorf, Germany

Busch, HL:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Dept Internal Med, Moorenstr 5, D-40225 Dusseldorf, Germany

Devito, F:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Bari, DETO, Bari, Italy

Sionis, A:
 Hosp Santa Creu & Sant Pau, Dept Cardiol, Intens Cardiac Care Unit, Barcelona, Spain

Ciccone, MM:
 MED Res Network, SIRIO, Dusseldorf, Germany

 Univ Bari, DETO, Bari, Italy
ISSN: 20556837





European Heart Journal-Cardiovascular Pharmacotherapy
Editorial
OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, Reino Unido
Tipo de documento: Review
Volumen: 2 Número: 1
Páginas: 44-53
WOS Id: 000383330500009
ID de PubMed: 27533061
imagen Bronze, Green Published

MÉTRICAS